Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken

Veterinary Immunology and Immunopathology

Volumn 115, Issue 3-4, 2007, Pages 216-222

  Linghua, Zhang ^a   Xingshan, Tian ^b   Fengzhen, Zhou ^b  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF ANIMAL SCIENCE   (China)

Author keywords

CpG ODN; Immune response; Newcastle disease (ND) vaccine; The SPF chicken

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; NEWCASTLE DISEASE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; DATA ANALYSIS; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; LETHAL DOSE; LYMPHOCYTE PROLIFERATION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; STATISTICAL SIGNIFICANCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; LYMPHOCYTES; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; OLIGODEOXYRIBONUCLEOTIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL VACCINES;

AVES; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 33846338137     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.10.017     Document Type: Article

References (38)

1. Ballas Z.K., Rasmussen W.L., and Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157 (1996) 1840-1845
2. Brazolot Millan C.L., Weeratna R., Krieg A.M., Siegrist C.A., and Davis H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15553-15558
3. Carpentier A.F., Chen L., Maltonti F., and Delattre J.Y. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mic. Cancer. Res. 59 (1999) 5429-5432
4. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T Helper 1 (Th1) immunity. J. Exp. Med. 186 10 (1997) 1623-1631
5. Davis H.L., Suparto I.I., Weeratna R.R., Iskandriati D.D., Chamzah S.S., Ma'ruf A.A., Nente C.C., Pawitri D.D., Krieg A.M., Heriyanto S.W., and Sajuthi D.D. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 18 18 (2000) 1920-1924
6. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Method 89 (1986) 271-277
7. Heeg L., and Zimmermann S. CpG DNA as a Th1 trigger. Int. Arch. Allergy Immunol. 121 (2000) 87-97
8. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. AToll-like receptor recognizes bacterial DNA. Nature 408 6813 (2000) 740-745
9. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 9 (2002) 4531-4537
10. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and van Drunen Little-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21 (2002) 127-137
11. Jakob T., Walker P.S., Krieg A.M., Udey M.C., and Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161 (1998) 3042-3049
12. Kanellos T.S., Sylvester I.D., Butler V.L., Ambali A.G., Partidos C.D., Hamblin A.S., and Russel P.H. Mammalian granulocyte-macrophage colony stimulating factor and some CpG motifs have an effect on the immunogenicity of DNA and subunit vaccines in fish. Immunology 96 (1999) 507
13. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., and Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170 9 (2003) 4465-4474
14. Klinman D.M., Barnhart K.M., and Conover J. CpG motifs as immune adjuvants. Vaccine 17 (1999) 19-25
15. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
16. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
17. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., and Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98 (1996) 1119-1129
18. Madansky C.H., and Bratt M.A. Noncytopathic mutants of Newcastle disease virus. J. Virol. 26 3 (1978) 724-729
19. Masuda K., Sakaguchi M., Saito S., Deboer D.J., Fujiwara S., Kurata K., Yamashita K., Hasegawa A., Ohno K., and Tsujimoto H. In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs. J. Vet. Med. Sci. 62 (2000) 995-1000
20. Messina J.P., Gilkeson G.S., and Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147 (1991) 1759-1764
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Method 65 (1983) 55-63
22. Pisetsky D.S. Immune activation by bacterial DNA: a new genetic code. Immunity 5 (1996) 303-310
23. Pontarollo R.A., Rankin R., Babiuk L.A., Godson D.L., Griebel P.J., Hecker R., Krieg A.M., and van Drunen Little-van den Hurk S. Monocytes are required for optimun in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet. Immunol. Immunopathol. 84 1/2 (2002) 43-59
24. Rankin R., Pontarollo R., Gomis S.M., Karvonen B., Willson P., and Loehr B.I. CpG containing oligodeoxynucleotides augment and switch immune responses of cattle to bovine herpesvirus-1. Vaccine 20 (2002) 3014-3022
25. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., and van Drunen Little-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acids Drug Dev. 11 5 (2001) 3333-3340
26. Ricardo S.C., and Patricia B.P. CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19 (2001) 234-242
27. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., and Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature 3 8 (1997) 849-854
28. Rothenfusser S., Hornung V., Krug A., Towarowski A., Krieg A.M., Endres S., and Hartmann G. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur. J. Immunol. 31 12 (2001) 3525-3534
29. Sparwasser T., Koch E.V., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., and Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28 (1998) 2045-2054
30. Sun S., Zhang X., Tough D.F., and Sprent J. Type 1 interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 188 12 (1998) 2335-2342
31. Takeshita F., Leifer C.A., Gursel I., Ishii K.J., Takeshita S., Gursel M., and Klinman D.M. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167 7 (2001) 3555-3558
32. Takeshita S., Takeshita F., Haddad D.E., Ishii K.J., and Klinman D.M. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol. 206 (2000) 101-106
33. Threadgill D.S., McCormick L.L., McCool T.L., Greenspan N.S., and Schreiber J.R. Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide. Vaccine 16 (1998) 76-82
34. Van der Stede Y., Verdonck F., Vancaeneghem S., Cox E., and Goddeeris B.M. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet. Immunol. Immunopathol. 86 (2002) 31-41
35. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., and Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CpG-motifs. J. Immunol. 166 (2001) 2372-2377
36. Vleugels B., Ververken C., and Goddeeris B.M. Stimulatory effect of CpG sequences on humoral response in chickens. Poult. Sci. 81 (2002) 1317-1321
37. Wai M.L., Marcel B.B., Marie-Paule, and Schutze-Redelmeier. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes. Vaccine 20 (2002) 148-157
38. Waterson A.P., Pennington T.H., and Allan W.H. Virulence in Newcastle disease virus A preliminary study. Br. Med. Bull. 23 2 (1967) 138-143